Clinical Trials Directory

Trials / Completed

CompletedNCT05730400

Histological Assessment of BMAC Utilized in Sinus Lift

Histological Assessment of Deproteinized Bovine Bone Loaded by Bone Marrow Aspirate Versus Deproteinized Bovine Bone Alone for Guided Sinus Floor Elevation. (A Randomized Controlled Clinical Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Aim : The aim of present study was to evaluate BMAC/bovine graft utilization in Sinus membrane augmentation on bone quality and quantity. Methodology: sixteen patients suffering from atrophic posterior maxilla with sinus pneumatization were randomly divided into two equal groups: study group: the sinus membrane was elevated with BMAC/bovine graft whereas the control group recieved bovine graft only for sinus floor augmentation. All patients will be evaluated at 1 week, 4 months to measure bone height and bone core biopsy for histological assessment at 4 months during implant placement.

Detailed description

Aim : The aim of present study was to evaluate BMAC/bovine graft utilization in Sinus membrane augmentation on bone height gain and quality of bone on histological assessment. Methodology: sixteen patients suffering from atrophic posterior maxilla with sinus pneumatization were randomly divided into two equal groups: study group: the sinus membrane was elevated with bone marrow aspirate concentrate loaded on bovine graft whereas the control group recieved bovine graft only for sinus floor augmentation. All patients will be evaluated at 1 week, 4 months by CBCT to measure bone height and bone core biopsy for histological assessment at 4 months during implant placement.

Conditions

Interventions

TypeNameDescription
DRUGBMAC loaded on bovine graftBone marrow aspirate concentrate loaded on bovine graft for sinus floor augmentation
DRUGBovine graft onlyBovine graft only for sinus floor augmentation

Timeline

Start date
2022-10-30
Primary completion
2023-08-30
Completion
2023-09-15
First posted
2023-02-15
Last updated
2024-02-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05730400. Inclusion in this directory is not an endorsement.